Oil markets surged in the hrs just after Pfizer introduced optimistic benefits from its coronavirus vaccine review. Dado Ruvic/Reuters

The Trump administration declined an offer from Pfizer for additional doses of its COVID-19 vaccine in late summer time, according to the New York Times. 

The US may possibly struggle to safe further doses of the vaccine presented Pfizer’s commitments to other nations. 

The Trump administration procured 100 million doses of Pfizer’s vaccine, but it truly is a two-dose treatment method so it will only go to 50 million People.

Go to Company Insider’s homepage for extra tales.

The Trump administration declined an give from Pfizer in late summer months for more COVID-19 vaccine doses, the New York Periods claimed on Monday, citing men and women familiar with the make a difference. 

This indicates that Us residents may well battle to get extra doses of Pfizer’s COVID-19 vaccine presented commitments it’s made to other nations around the world, the Instances said. Pfizer may possibly not be capable to supply extra doses to the US until eventually up coming June, however it’s not the only pharmaceutical company which is generated a COVID-19 vaccine.

A senior administration formal advised reporters on a connect with on Monday that the New York Periods story was “phony,” a single formal adding, “I am going to also notify you we are in the center of a negotiation proper now, and are unable to talk publicly about it, but we sense certainly self-assured we will get the vaccine doses for which we’ve contracted and we are going to have adequate range of doses to vaccinate all People who need just one before the conclude of the next quarter 2021.”

The White Property did not immediately answer to a request for remark from Insider.

“[The U.S. government placed an initial order of 100 million doses for Pfizer-BioNTech’s COVID-19 vaccine and Pfizer is ready to begin shipping initial doses soon after receiving an Emergency Use Authorization from FDA,” Pfizer said in a statement. “Any additional doses beyond the 100 million are subject to a separate and mutually-acceptable agreement. The company is not able to comment on any confidential discussions that may be taking place with the U.S. government.”

Story continues

“Recognizing the urgency of the need, our manufacturing teams have been working around the clock so we can bring the vaccine to the world as quickly, efficiently and equitably as possible,” the statement added.

The Trump administration purchased 100 million doses of Pfizer’s vaccine as part of Operation Warp Speed, the government’s initiative to accelerate the development and distribution of a vaccine. But Pfizer’s vaccine is a two-dose treatment, so 100 million doses will go to 50 million Americans.

“We are confident that we will have 100 million doses of Pfizer’s vaccine as agreed to in our contract, and beyond that, we have five other vaccine candidates,” a spokesperson for the Department of Health and Human Services told the Times when asked if the Trump administration missed a “crucial” chance to purchase more of the vaccine. 

President Donald Trump and others in his administration have misleadingly suggested the Pfizer vaccine was developed as a result of Operation Warp Speed, but the pharmaceutical giant has maintained that it received no money from the government in that regard. 

Trump is set to hold a White House “Vaccine Summit” on Tuesday.

Pfizer and Moderna, which have both submitted applications to the Food and Drug Administration for emergency authorization for their COVID-19 vaccines, declined invitations to attend the summit, according to STAT.

In November, Trump baselessly accused Pfizer of delaying the news of its vaccine development success until after the election to hurt his chances. Trump has falsely claimed he won the election, and refused to concede to President-elect Joe Biden. 

“Pfizer and others even decided to not assess the results of their vaccine; in other words, not come out with a vaccine until just after the election,” Trump said at the time. 

In the days following the election, Pfizer announced that its vaccine was found to be more than 90% effective in preventing COVID-19.

Allana Akhtar contributed reporting.

Read the original article on Business Insider

Supply url